Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes
1. Once weekly efsitora demonstrated non-inferiority compared with degludec with regards to change in HbA1c. 2. Patients in the efsitora ...
Tag: Type 1 Diabetes Mellitus
Machine learning model non-invasively detects suspected cases of hypoglycemia during real-world driving
1. Machine learning (ML) models developed by Lehmann and colleagues used driving characteristics and head motion data to detect hypoglycemic ...
High dose aflibercept reduced treatment burden in patients with diabetic macular edema
1. Aflibercept 8 mg was non-inferior to 2 mg for best-corrected visual acuity at 48 weeks. 2. Ocular adverse events ...
#VisualAbstract: Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes
Click to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
#VisualAbstract: Continuous glucose monitoring in type 1 diabetes results in improved blood glucose levels
1. In patients with type 1 diabetes, using intermittently scanned continuous glucose monitoring resulted in significantly lower glycated hemoglobin levels ...
Individuals with autoimmune diseases may have an increased risk for cardiovascular diseases
1. An increased incidence of new cardiovascular disease was seen in individuals with autoimmune disease compared to those without. 2. ...
Faricimab may improve visual acuity in patients with diabetic macular edema
1. Faricimab every 8 weeks and faricimab per personalized treatment interval (PTI) were noninferior to aflibercept for mean change in ...
Increased prevalence of type 1 and type 2 diabetes observed in youths in the United States, 2001 to 2017
1. This cross-sectional study discovered that the estimated prevalence of both type 1 and type 2 diabetes among youths in ...
Study identifies distinct hemoglobin A1c patterns in adolescents over time
1. Across 3 international registries, 5 similar patterns of hemoglobin A1c (HbA1c) were identified: low stable, intermediate stable, high stable, target ...
Real-time continuous glucose monitoring improves glycemic control compared to intermittently scanned monitoring for patients with type 1 diabetes
1. Time in range after 6 months was higher with rtCGM than with isCGM. 2. Participants on rtCGM scored better ...